S3169 — Permits terminally ill patients to access investigational therapies; allows corporation business tax credit and gross income tax credit for certain investigational therapies available to terminally ill patients.

S3169 — Permits terminally ill patients to access investigational therapies; allows corporation business tax credit and gross income tax credit for certain investigational therapies available to terminally ill patients. · Informed CitizenryThis bill allows terminally ill patients to access investigational therapies, defined as drugs, biological products, or devices that have completed Phase I clinical trials but lack FDA approval for…Open in Informed Citizenry